跳至主要内容
临床试验/JPRN-UMIN000035382
JPRN-UMIN000035382尚未招募未知

Compare the efficacy of diagnostic treatment with P-CAB and PPI before to do endoscopy for GERD patients. - Compare the efficacy of treatment with P-CAB and PPI in patients with GERD.

Kitasato University0 个研究点目标入组 100 人开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with a history of hypersensitivity to components of Vonoprazan and Esomeprazole. 2.Patients taking PPI including Vonoprazan and Esomeprazole. 3.Patients taking Atazanavir sulfate and Rilpivirine hydrochloride. 4.Patients who are diagnosed Zollinger-Ellison syndrome and Pernicious anemia. 5.Patients who have complicated other severe diseases and whose clinical trials can not be safety performed or whose effect judgment is difficult. 6.Patients with malignant tumor complications. 7.Patients with a history of surgery of the upper gastrointestinal tract including the stomach and esophagus. 8.Patients who may be pregnant or pregnant. 9.Patients who judged by physician inappropriate to participate in clinical trials.

研究者

相似试验